Thursday, February 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Groupon Shares Surge as Analysts Issue Bullish Upgrades

Robert Sasse by Robert Sasse
September 21, 2025
in Analysis, E-Commerce, Nasdaq
0
Groupon Stock
0
SHARES
109
VIEWS
Share on FacebookShare on Twitter

Groupon shares concluded Friday’s trading session with modest gains, fluctuating between $22.52 and $22.66. This positive movement suggests potential stabilization following a period of weaker weekly performance.

Significant Price Target Revisions Fuel Momentum

Market analysts have demonstrated renewed confidence in the deal platform operator through substantial upward revisions. Roth Capital elevated its price objective from $33 to $47, while Northland Securities increased its target from $39 to $44. The collective consensus price target now stands at $29.80.

Further reinforcing this optimistic outlook, the Zacks Consensus Estimate for Groupon’s full-year earnings per share has been revised upward by a remarkable 31.1% over the past month, now projecting $0.80. This overwhelming analyst endorsement has earned Groupon the prestigious Zacks Rank #1 (Strong Buy) designation.

Strong Quarterly Performance Underpins Confidence

The company’s recent quarterly report, released on August 6, substantially exceeded market expectations. Rather than reporting an anticipated loss of $0.02 per share, Groupon announced a profit of $0.46 per share. Revenue performance also surpassed forecasts, with actual figures reaching $125.70 million compared to the projected $122.46 million.

Should investors sell immediately? Or is it worth buying Groupon?

Institutional Investment Signals Growing Interest

Adding to the positive indicators, Range Financial Group LLC established a significant position during the second quarter, investing $1.26 million to acquire 37,764 Groupon shares. Such institutional accumulation typically reflects well-researched conviction in a company’s prospects.

From a technical analysis perspective, the equity generated a buy signal from a bottom formation on Wednesday. Friday’s trading session provided additional confirmation for bullish investors through increased trading volume accompanied by price appreciation.

Despite these encouraging developments, moving averages continue to indicate potential resistance levels. The stock’s weekly performance through September 19 remained subdued, showing a decline of 1.36%.

Market participants now await Groupon’s next earnings announcement scheduled for November 11. Current analyst consensus maintains a “Moderate Buy” recommendation with the $29.80 average price target suggesting substantial potential upside from current trading levels.

Ad

Groupon Stock: Buy or Sell?! New Groupon Analysis from February 5 delivers the answer:

The latest Groupon figures speak for themselves: Urgent action needed for Groupon investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 5.

Groupon: Buy or sell? Read more here...

Tags: Groupon
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

CrowdStrike Stock
Analysis

CrowdStrike Shares Face Headwinds Amid Mixed Signals

February 5, 2026
Viking Therapeutics Stock
Analysis

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

February 5, 2026
Solana Stock
Analysis

Solana Faces Billions in Potential Token Supply Releases

February 5, 2026
Next Post
Century Therapeutics Stock

Is Century Therapeutics Stock a High-Stakes Turnaround Play?

Union Pacific Stock

Political Backing Fuels Speculation Over Major Railroad Merger

Waterstone Stock

Waterstone Financial Shares Show Resilience Amid Sector Volatility

Recommended

Gerresheimer Stock

Gerresheimer Shares Plunge Amid Deepening Crisis

4 months ago
Alphabet Stock

Regulatory Pressure Mounts on Alphabet as UK Designates Search Dominance

4 months ago
Technology Data analytics stock Trading (1)

Revolutionizing Ad Monetization Brightcove and Google Ad Manager Join Forces

2 years ago
MMP stock news

Yousif Capital Management Reduces Holdings in Alarm.com, Inc. – Analyzing Impact on Future Prospects

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

Solana Faces Billions in Potential Token Supply Releases

CureVac Delisted Following BioNTech Acquisition Completion

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

PC Connection Set to Report Full-Year and Fourth Quarter Earnings

Trending

CrowdStrike Stock
Analysis

CrowdStrike Shares Face Headwinds Amid Mixed Signals

by Andreas Sommer
February 5, 2026
0

The investment case for cybersecurity leader CrowdStrike is currently being shaped by conflicting developments. Positive legal news...

NCR Stock

NCR Voyix Charts a Course Toward Cloud-Centric Growth

February 5, 2026
Rolls Royce Stock

Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

February 5, 2026
Viking Therapeutics Stock

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

February 5, 2026
Solana Stock

Solana Faces Billions in Potential Token Supply Releases

February 5, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • CrowdStrike Shares Face Headwinds Amid Mixed Signals
  • NCR Voyix Charts a Course Toward Cloud-Centric Growth
  • Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com